Bessemer Group
MDGL icon

Bessemer Group’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bessemer Group’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13K Hold
24
– – ﹤0.01% 2047
2025
Q4 		$14K Buy
24
+19
+380% +$9.7K ﹤0.01% 1994
2025
Q3 		$2K Hold
5
– – ﹤0.01% 2332
2025
Q2 		$2K Hold
5
– – ﹤0.01% 2224
2025
Q1 		$2K Sell
5
-5
-50% -$1.64K ﹤0.01% 2250
2024
Q4 		$3K Hold
10
– – ﹤0.01% 2137
2024
Q3 		$2K Buy
+10
New +$2.56K ﹤0.01% 2234
2019
Q1 		– Sell
-1,033
Closed -$116K – 1888
2018
Q4 		$116K Buy
+1,033
New +$160K ﹤0.01% 1125
2015
Q4 		– Sell
-16
Closed -$1K – 1667
2015
Q3 		$1K Buy
+16
New +$1.16K ﹤0.01% 1546

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return